Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Kyntra Bio (KYNB) over the last 10 years, with Q4 2024 value amounting to $5.9 million.

  • Kyntra Bio's Non-cash Items rose 699156.63% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.9 million, marking a year-over-year increase of 699156.63%. This contributed to the annual value of $5.9 million for FY2024, which is 699156.63% up from last year.
  • According to the latest figures from Q4 2024, Kyntra Bio's Non-cash Items is $5.9 million, which was up 699156.63% from $83000.0 recorded in Q4 2023.
  • Kyntra Bio's 5-year Non-cash Items high stood at $86.0 million for Q4 2020, and its period low was $83000.0 during Q4 2023.
  • In the last 5 years, Kyntra Bio's Non-cash Items had a median value of $4.7 million in 2022 and averaged $19.9 million.
  • As far as peak fluctuations go, Kyntra Bio's Non-cash Items tumbled by 9824.52% in 2023, and later skyrocketed by 699156.63% in 2024.
  • Kyntra Bio's Non-cash Items (Quarter) stood at $86.0 million in 2020, then tumbled by 96.95% to $2.6 million in 2021, then surged by 80.4% to $4.7 million in 2022, then tumbled by 98.25% to $83000.0 in 2023, then skyrocketed by 6991.57% to $5.9 million in 2024.
  • Its Non-cash Items was $5.9 million in Q4 2024, compared to $83000.0 in Q4 2023 and $4.7 million in Q4 2022.